Virtual reality vs. relaxing videos: a new weapon against chemo side effects?

NCT ID NCT06863623

Completed Symptom relief Sponsor: Hacettepe University Source: ClinicalTrials.gov ↗

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests whether immersive virtual reality or relaxing nature videos can reduce symptom severity, distress, and improve quality of life in people with lung cancer who are starting chemotherapy. Participants will be randomly assigned to one of three groups: virtual reality sessions, relaxing videos, or standard care. The goal is to see if these calming, non-drug methods can help manage common chemotherapy side effects like nausea, fatigue, and emotional distress.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: immersive virtual reality and relaxing videos
What this could lead to: If effective, these non-drug approaches could offer a simple, drug-free way to reduce symptom severity and distress during chemotherapy.
What could go wrong: This is a relatively small, early-stage trial. The effects may be modest, and not all patients may tolerate or benefit from virtual reality or video interventions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY EFFECT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chemotherapy-induced toxicity lung cancer lung neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHEMOTHERAPY EFFECT DISTRESS, EMOTIONAL LUNG CANCER QUALITY OF LIFE (QOL)

Contacts and locations

Locations

Ankara Bilkent City Hospital

Ankara, Çankaya, 06800, Turkey (Türkiye)
Ankara Etlik City Hospital

Ankara, Yenimahalle, 06170, Turkey (Türkiye)
Hacettepe University Oncology Hospital

Ankara, Altındağ, 06230, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.